未登录

S

Sunshin Kim

National Cancer Center

H指数:26

被引数:2,714

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer

VEGF信号复杂性赋予对阿特珠单抗、贝伐珠单抗、卡铂和紫杉醇的抵抗作用，见于EGFR酪氨酸激酶抑制剂耐药的非小细胞肺癌

IF10.7

2025-08-190

OAAI

Overcoming MET-targeted drug resistance in MET-amplified lung cancer by aurora kinase B inhibition

通过抑制Aurora kinase B克服MET扩增型肺癌的MET靶向药物耐药性

biochimica et biophysica acta molecular cell research

IF0

2025-06-090

OAAI

Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer

BRITISH JOURNAL OF CANCER

IF6.8

2023-04-145

PRE

Patient-derived cellbased pharmacogenomic platform to uncover resistance mechanisms and novel therapeutics for advanced lung cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Pharmacogenomic platform using patient- derived cells to delineate tumor heterogeneity and therapeutic response of refractory lung cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Inhibiting ataxiatelangiectasia mutated and RAD3related (ATR) by BAY 1895344 overcomes chemoresistance to oxaliplatin and promotes synergistic anti-tumor effect in pancreatic cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

ICX-101, a novel MYC inhibitor, shows antitumor activity in patient-derived cells of advanced lung cancer with high MYC expression

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Targeting aurora kinase b overcomes acquired resistance to met-tyrosine kinase inhibitor in met-amplified lung cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Ataxia-Telangiectasia Mutated Is Involved in Autolysosome Formation

BIOMOLECULES & THERAPEUTICS

IF3.2

2023-03-213

OAAI

Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2023-01-309

OAAI

MYC amplification-conferred primary resistance to capmatinib in a MET-amplified NSCLC patient: a case report

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2022-09-013

OAAI

Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2022-08-233

OAAI

A fusion of CD63-BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis

BRITISH JOURNAL OF CANCER

IF6.8

2020-11-1810

OAAI

Regulation of mRNA export through API5 and nuclear FGF2 interaction

NUCLEIC ACIDS RESEARCH

IF13.1

2020-05-0829

OAAI

NEDD4L downregulates autophagy and cell growth by modulating ULK1 and a glutamine transporter

CELL DEATH & DISEASE

IF9.6

2020-01-2071

OAAI

GenomomFF: Cost-Effective Method to Measure Fetal Fraction by Adaptive Multiple Regression Techniques With Optimally Selected Autosomal Chromosome Regions

IF3.6

2020-01-012

OAAI

EI24, as a Component of Autophagy, Is Involved in Pancreatic Cell Proliferation

FRONTIERS IN ONCOLOGY

IF3.3

2019-07-2318

OAAI

Histone variant H3F3A promotes lung cancer cell migration through intronic regulation

NATURE COMMUNICATIONS

IF15.7

2016-10-0340

OAAI

High-throughput cell-based screening of drug library identifies albendazole as a sensitizer with combination of bortezomib for treatment multiple myeloma

CANCER RESEARCH

IF16.6

2014-10-012

PRE

Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2014-07-18143

OAAI